The rise of biologics and biosimilars is a key growth driver inside the Pharma Hub Patient Access Support Service Market, as complex‑modality drugs require sophisticated support‑infrastructures. Pharma Hub Patient Access Support Service Market High‑cost biologics and reimbursement‑complexity Monoclonal antibodies, immunomodulators, and oncology‑linked biologics often require...